<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
S C H E D U L E 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
CARDIAC SCIENCE, INC.
- -------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.001 PAR VALUE
- -------------------------------------------------------------------------------
(Title of Class of Securities)
141410209
------------------------
(CUSIP Number)
Ernst Muller-Mohl
Weinplatz 10
8001 Zurich, Switzerland
Tel # 41-1-212-0424
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Persons
Authorized to Receive Notices and Communications)
September 30, 1999
- -------------------------------------------------------------------------------
(Date of Event which Requires Filing this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13-d-1(g), check the following
space .
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that Section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
- 1 of 5 -
<PAGE>
CUSIP
No. 141410209 13D
- -------------------------------------------------------------------------------
1 Name of Reporting Person
I.R.S. Identification No. of Above Person
Ernst Muller-Mohl
- -------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group* (a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC Use Only
- -------------------------------------------------------------------------------
4 Source of Funds* PF
- -------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required / /
- -------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Switzerland
- -------------------------------------------------------------------------------
7 Sole Voting Power
2,983,750 shares 26.4%
Number of --------------------------------------------------------------
Shares 8 Shared Voting Power
Beneficially 0 shares 0%
Owned By --------------------------------------------------------------
Each 9 Sole Dispositive Power
Reporting 2,983,750 shares 26.4%
Person --------------------------------------------------------------
With 10 Shared Dispositive Power
0 shares 0%
- -------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned By Each Reporting Person
2,983,750 shares
- -------------------------------------------------------------------------------
12 Check Box if the Aggregate Amount in Row (11) excludes Certain Shares*
/ /
- 2 of 5 -
<PAGE>
- -------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
26.4%
- -------------------------------------------------------------------------------
14 Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
- 3 of 5 -
<PAGE>
This Amendment No. 3 (this "Amendment") to the Schedule 13D, dated
December 27, 1998 (the "Schedule"), pertains to the reporting person's ownership
of certain securities of Cardiac Science, Inc. (the "Issuer"). All capitalized
terms used herein and otherwise undefined shall have the meanings ascribed to
them in the Schedule.
This Amendment is filed in accordance with Rule 13d-2 of the Securities
Exchange Act of 1934, as amended, by the reporting person. It refers only to
information which has materially changed since the filing of Amendment No. 2 to
the Schedule.
ITEM 5. INTERESTS IN SECURITIES OF THE ISSUER.
(a) Aggregate number of shares beneficially owned: 2,983,750(1)
shares
Percentage: 26.4%(2)
(b) Mr. Muller-Mohl has sole power to vote or to direct the vote and
to dispose or direct the disposition of 2,983,750(1) shares of Common Stock.
(c) On September 30, 1999, Mr. Muller-Mohl purchased from the
Company, in a Regulation S transaction, 375,000 shares of Common Stock and
three-year warrants to purchase 56,250 shares of Common Stock at $5.00 per
share. The aggregate purchase price of the Common Stock and warrants was
$1,500,000.
- --------
(1) Includes 56,250 shares issuable upon the exercise of warrants held by
Mr. Muller-Mohl.
(2) Based on 11,244,732 shares of Common Stock outstanding.
- 4 of 5 -
<PAGE>
Signature
After reasonable inquiry and to the best of the undersigned's
knowledge and belief, the undersigned hereby certifies that the information set
forth in this statement is true, complete, and correct.
Date: October 18, 1999
/s/ Ernst Muller-Mohl
--------------------------------------------
Ernst Muller-Mohl
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT
CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001).
- 5 of 5 -
